The Dow Jones Industrial Average (DJINDICES: ^DJI) was clinging to a small gain Tuesday afternoon, up 0.12% at 12:30 p.m. EST. The coronavirus outbreak that originated in China surpassed 1,000 deaths and 40,000 cases, and the global economic impact remains unclear. However, the
Exelixis (NASDAQ: EXEL) already markets cabozantinib as a treatment for kidney cancer and liver cancer; its latest results suggest it may secure approval for its use in prostate cancer someday, too.
Lyft, Inc. LYFT is set to report fourth-quarter results on Feb 11, after market close. Lyft’s top line is likely to have benefited from high customer adoption. Its cheap pricing strategy is expected to have helped it gain market share over its rivals.
Tempur Sealy International, Inc. TPX is slated to report fourth-quarter 2019 results on Feb 13, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.30 per share beat the Zacks Consensus Estimate by 15% and revenues of $821 million outpac
Omnicom OMC reported fourth-quarter 2019 earnings per share of $1.89 (on an adjusted basis) which beat the Zacks Consensus Estimate by 2 cents. Earnings increased 12 cents year over year.
Hess Corporation HES has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at HES given that, according to its RSI reading of 29.51, it is now in oversol
Genesco Inc. GCO has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at GCO given that, according to its RSI reading of 28.85, it is now in oversold te